These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 34054810)

  • 1. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.
    Reens AL; Cabral DJ; Liang X; Norton JE; Therien AG; Hazuda DJ; Swaminathan G
    Front Immunol; 2021; 12():643255. PubMed ID: 34054810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites.
    Malczewski AB; Ketheesan N; Coward JIG; Navarro S
    Front Immunol; 2021; 12():624434. PubMed ID: 34305883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy.
    Yin Q; Ni JJ; Ying JE
    Immun Inflamm Dis; 2024 Jul; 12(7):e1263. PubMed ID: 39031507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
    Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of immunomodulatory drugs on the gut microbiota.
    Cohen I; Ruff WE; Longbrake EE
    Transl Res; 2021 Jul; 233():144-161. PubMed ID: 33515779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not？.
    Xiaoyu P; Chao G; Lihua D; Pengyu C
    Gut Microbes; 2020 Jul; 11(4):691-705. PubMed ID: 32216675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review.
    Halsey T; Ologun G; Wargo J; Jenq RR
    Semin Hematol; 2020 Jan; 57(1):13-18. PubMed ID: 32690139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review.
    Cruellas M; Yubero A; Zapata M; Galvez EM; Gascón M; Isla D; Lastra R; Martínez-Lostao L; Ocariz M; Pardo J; Ramírez A; Sesma A; Torres-Ramón I; Paño JR
    Infect Immun; 2021 Aug; 89(9):e0066520. PubMed ID: 33526567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.
    Thompson NA; Stewart GD; Welsh SJ; Doherty GJ; Robinson MJ; Neville BA; Vervier K; Harris SR; Adams DJ; Dalchau K; Bruce D; Demiris N; Lawley TD; Corrie PG
    BMC Cancer; 2022 Jan; 22(1):99. PubMed ID: 35073853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the microbiota in response to and recovery from cancer therapy.
    Blake SJ; Wolf Y; Boursi B; Lynn DJ
    Nat Rev Immunol; 2024 May; 24(5):308-325. PubMed ID: 37932511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting gut microbiota for immunotherapy of diseases.
    Yu YJ; Liu XD; Liao C; Yu R; Wang X; Li M; Wang Y
    Arch Toxicol; 2024 Aug; 98(8):2429-2439. PubMed ID: 38722348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
    Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
    Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.